Drawing for FENT

USPTO serial 90846994

FENT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
THOMA, GABRIELLE M
Law office
TMO LAW OFFICE 127

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with FENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jason C. Cameron

Jason C. Cameron JCAMERON IP LAW FIRM LLC13102 PLUMWOOD DRIVECYPRESS, TX 77429United States

Goods and services

ClassDescriptionStatusFirst use
009Semiconductors; Semiconductor apparatus, namely, devices and testing apparatus for molecular analysis and diagnostics and for readout of DNA data storage and DNA memory; Semiconductor devices; Semiconductor chips; Semiconductor devices, namely, semiconductor life science tool power elements; Semiconductor testing apparatus; Transistors; Transistor testers; Medical laboratory research instruments, namely, diagnostic, examination, and monitoring equipment, namely, tools and instruments for molecular analysis and diagnostics and readout of data stored in DNA or other biopolymers; Software as a Medical Device (SaMD), downloadable, for diagnosing prognosis of diseases, namely, cancer, and precision medicine; Medical laboratory research instruments for molecular analysis and diagnostics and precision medicineACTIVESep 20, 2019
010Medical diagnostic instruments for molecular analysis, assays, diagnosis of cancer and for precision medicine; Electromedical diagnostic instruments for molecular analysis, diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Tools for medical diagnostics, namely, diagnostic apparatus for the detection of cancer, namely, life science tools, instruments and systems, namely, medical imaging apparatus with embedded operating system software, for molecular analysis, diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Diagnostic apparatus for medical purposes, namely, for molecular analysis, diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Diagnostic instruments for medical use, namely, for molecular analysis, diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Medical diagnostic, examination, and monitoring equipment, namely, diagnostic apparatus for molecular analysis, diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Medical diagnostic apparatus for medical purposes, namely, molecular analysis tools for testing DNA and RNA samples, namely, DNA, RNA, and protein sequencing; Apparatus for carrying-out diagnostic tests for medical purposes, namely, tools, systems, namely, medical imaging apparatus with embedded operating system software, and instruments for molecular analysis, diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Medical apparatus and devices for diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Medical testing instruments for detecting disease, namely, cancer, early and for precision medicine; Medical analysis instruments for testing DNA, RNA, proteins, metabolites, lipids, multi-omicsACTIVESep 20, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 28, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 28, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 12, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 12, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 15, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 15, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 15, 2024CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2024ALIEASSIGNED TO LIE—
Oct 17, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 19, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2023CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 18, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 17, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 20, 2023IUAFUSE AMENDMENT FILED—
Jun 20, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 20, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 25, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 25, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 5, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 20, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 19, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Sep 19, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 19, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 19, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 30, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Aug 30, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 30, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 30, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 12, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 11, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 11, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 15, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 15, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 15, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 10, 2022DOCKASSIGNED TO EXAMINER—
Sep 23, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance